G1 Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for G1 THERAP, and when can generic versions of G1 THERAP drugs launch?
G1 THERAP has one approved drug.
There are twelve US patents protecting G1 THERAP drugs.
There are one hundred and twenty-five patent family members on G1 THERAP drugs in twenty-seven countries.
Drugs and US Patents for G1 Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G1 Therap | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 11,717,523 | ⤷ Sign Up | ⤷ Sign Up | ||||
G1 Therap | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 10,189,849 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
G1 Therap | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 10,189,850 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
G1 Therap | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 9,487,530 | ⤷ Sign Up | ⤷ Sign Up | ||||
G1 Therap | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 10,085,992 | ⤷ Sign Up | ⤷ Sign Up | ||||
G1 Therap | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 11,040,042 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
G1 Therap | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 8,598,197 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for G1 Therap Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Russian Federation | 2019120160 | ⤷ Sign Up |
Canada | 2906166 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2014144740 | ⤷ Sign Up |
Slovenia | 2968290 | ⤷ Sign Up |
Japan | 2016518337 | ⤷ Sign Up |
China | 105473140 | ⤷ Sign Up |
South Korea | 20240023676 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.